BENDAMUSTINE PLUS RITUXIMAB IN 65 YEAR AND ABOVE UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

被引：0
|
作者：
De La Fuente, A. [1 ]
Beneit, P. [2 ]
Gutierrez, A. [3 ]
Callejas, M. [4 ]
Garcia Marco, J. A. [5 ]
Garcia Malo, M. D. [6 ]
de la Serna, J. [7 ]
Gonzalez Gascon y Marin, I. [8 ]
Garcia Sanchis, L. [9 ]
Ballesteros, M. [10 ]
Jarque, I. [11 ]
Ochoa Grullon, J. [12 ]
Iglesias, R.
Estevez, M. [1 ]
de Ona, R. [1 ]
Prieto, E. [13 ]
Diaz-Lopez, A. [14 ]
Baltasar, P. [15 ]
机构：
[1] MD Anderson CC Madrid Spain, Hematol, Madrid, Spain
[2] H San Juan, Hematol, Alicante, Spain
[3] HU Son Espases, Hematol, Palma De Mallorca, Spain
[4] HU Principe Asturias, Hematol, Alcala De Henares, Spain
[5] HU Puerta Hierro Majadahonda, Hematol, Madrid, Spain
[6] HGU Morales Meseguer, Hematol, Murcia, Spain
[7] HU 12 Octubre, Hematol, Madrid, Spain
[8] H Infanta Leonor, Hematol, Madrid, Spain
[9] H Gen Castellon, Hematol, Castellon de La Plana, Spain
[10] GU Gregorio Maranon, Hematol, Madrid, Spain
[11] HU La Fe, Hematol, Valencia, Spain
[12] H Clin San Carlos, Inmunol, Madrid, Spain
[13] Hosp Fdn Jimenez Diaz, Hematol, Madrid, Spain
[14] Fdn MD Anderson, Traslat Med, Madrid, Spain
[15] HU La Paz, Hematol, Madrid, Spain
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1082
引用
收藏
页码：445 / 445
页数：1
相关论文
共 50 条
  • [1] Bendamustine plus rituximab in untreated chronic lymphocytic leukemia patients. The MDA-CLL-2015-02 study
    De La Fuente, Adolfo
    Navas, Begona
    Gutierrez, Antonio
    Jose Terol, Maria
    Callejas, Marta
    Garcia Marco, Jose Antonio
    Dolores Garcia-Malo, Maria
    de la Serna, Javier
    Teresa Gonzalez-Gascon y Marin, Isabel
    Sanchis, Laura Garcia
    Ballesteros, Monia
    Benavente, Celina
    Jarque, Isidro
    Ochoa Gullon, Juliana
    Beneit, Paola
    de Ona, Raquel
    Montalabn, Carlos
    Estevez, Monica
    Iglesias, Rebeca
    Diaz-Lopez, Antonio
    Baltasar, Patricia
    LEUKEMIA & LYMPHOMA, 2017, 58 : 200 - 201
  • [2] Cost-Effectiveness of Zanubrutinib Versus Bendamustine and Rituximab in Patients With Untreated Chronic Lymphocytic Leukemia
    Nie, Jing
    Liu, Lihui
    Wu, Huina
    Yuan, Shan
    Tang, Ke
    Wu, Jiyong
    CLINICAL THERAPEUTICS, 2024, 46 (11) : 877 - 882
  • [3] Phase 1 study of lenalidomide, bendamustine, and rituximab in previously untreated patients with chronic lymphocytic leukemia
    Soumerai, Jacob D.
    Davids, Matthew S.
    Werner, Lillian
    Fisher, David C.
    Armand, Philippe
    Amrein, Philip C.
    Neuberg, Donna
    Hochberg, Ephraim P.
    Brown, Jennifer R.
    Abramson, Jeremy S.
    LEUKEMIA & LYMPHOMA, 2019, 60 (12) : 2931 - 2938
  • [4] Bendamustine and rituximab in combination with lenalidomide in patients with chronic lymphocytic leukemia
    Maurer, Christian
    Pflug, Natali
    Bahlo, Jasmin
    Kluth, Sandra
    Rhein, Christina
    Cramer, Paula
    Gross-Ophoff, Carolin
    Langerbeins, Petra
    Fink, Anna-Maria
    Eichhorst, Barbara
    Kreuzer, Karl-Anton
    Fischer, Norbert
    Tausch, Eugen
    Stilgenbauer, Stephan
    Boettcher, Sebastian
    Doehner, Hartmut
    Kneba, Michael
    Dreyling, Martin
    Binder, Mascha
    Hallek, Michael
    Wendtner, Clemens-Martin
    Bergmann, Manuela
    Fischer, Kirsten
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 97 (03) : 253 - 260
  • [5] Bendamustine plus rituximab in chronic lymphocytic leukemia: is there life in the old dog yet?
    Wendtner, Clemens-Martin
    HAEMATOLOGICA, 2018, 103 (04) : 563 - 564
  • [6] Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group
    Fischer, Kirsten
    Cramer, Paula
    Busch, Raymonde
    Boettcher, Sebastian
    Bahlo, Jasmin
    Schubert, Joeerg
    Pflueger, Karl H.
    Schott, Silke
    Goede, Valentin
    Isfort, Susanne
    von Tresckow, Julia
    Fink, Anna-Maria
    Buehler, Andreas
    Winkler, Dirk
    Kreuzer, Karl-Anton
    Staib, Peter
    Ritgen, Matthias
    Kneba, Michael
    Doehner, Hartmut
    Eichhorst, Barbara F.
    Hallek, Michael
    Stilgenbauer, Stephan
    Wendtner, Clemens-Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (26) : 3209 - 3216
  • [7] Bendamustine in Combination with Rituximab for Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients: An Italian Retrospective Multicentre Study
    Gentile, Massimo
    Ciolli, Stefania
    Molica, Stefano
    Di Renzo, Nicola
    Selleri, Carmine
    Villa, Maria Rosaria
    De Paolis, Maria Rosaria
    Scortechini, Ilaria
    Giannotta, Angela
    Minoia, Carla
    Rago, Angela
    Boncompagni, Riccardo
    Bonanno, Vincenza
    Levato, Luciano
    Musso, Maurizio
    Mastrullo, Lucia
    Melpignano, Angela
    Murru, Roberta
    Angelucci, Emanuele
    Tarantini, Giuseppe
    Caparrotti, Giuseppe
    Guarini, Attilio
    Ferrara, Felicetto
    Cimino, Giuseppe
    Zinzani, Pier Luigi
    Morabito, Fortunato
    BLOOD, 2014, 124 (21)
  • [8] Efficacy Of Bendamustine and Rituximab In Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
    Kataeva, Elena
    Golenkov, Anatoly
    Triphonova, Elena
    Dudina, Galina
    Mitina, Tatyana
    Lutskaya, Tatyana
    Vysotskaya, Ludmila
    Chernykh, Yulliya
    Zakharov, Sergey
    BLOOD, 2013, 122 (21)
  • [9] ECONOMIC EVALUATION OF BENDAMUSTINE PLUS RITUXIMAB IN THE FIRST-LINE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    Lachaine, J.
    Kouroukis, C. T.
    VALUE IN HEALTH, 2016, 19 (03) : A248 - A248
  • [10] Fludarabine plus rituximab for untreated B-cell chronic lymphocytic leukemia
    Castagna, L
    Sarina, B
    Santoro, A
    BLOOD, 2003, 102 (06) : 2309 - 2309
12345